BDBM476089 US10865208, Compound I-144::[(2R,3R,4S,5R)-5-(4-amino-3-{[(2R)-1-hydroxypropan-2-yl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate

SMILES CC(CO)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12

InChI Key InChIKey=OTIMURPVRWVZKU-RNCGBASLSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476089   

TargetUbiquitin-like modifier-activating enzyme ATG7(Homo sapiens (Human))
Millennium Pharmaceuticals

US Patent
LigandPNGBDBM476089(US10865208, Compound I-144 | [(2R,3R,4S,5R)-5-(4-a...)
Affinity DataIC50:  35nMAssay Description:The total volume of the ATG7 enzymatic assay is 50 μL and contains 50 mM HEPES Hemisodium (pH 7.5), 0.05% BSA, 0.01% Tween-20, 25 mM NaCl, 5 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent